Healthcare - Press Releases

RANCHO CUCAMONGA, Calif., June 30, 2025 /PRNewswire/ -- Inland Empire Health Plan (IEHP) Chief Operating Officer Susie White received the San Bernardino County Medical Society's (SBCMS) 2025 President's Award during its annual Installation of Officers and Award Recognition Dinner in Victorville on June 26.

Pet Insight Magazine recognizes ZYMOX as a category trailblazer.

AMSTERDAM, 1 de julio de 2025 /PRNewswire/ -- Coway, la empresa surcoreana lder en tecnologa de bienestar, ha lanzado en el mercado europeo el Airmega 50, el modelo ms compacto de su lnea de purificadores de aire hasta la fecha. Este nuevo lanzamiento aporta una purificacin de aire premium a espacios cotidianos, priorizando la portabilidad, el rendimiento y la tranquilidad.

TAIPEI and SHANGHAI and SAN FRANCISCO, July 1, 2025 /PRNewswire/ -- HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company developing innovative immunotherapies for oncology and autoimmune diseases, today announces the signing of a major out-licensing agreement with Shanghai Henlius Biotech, Inc. (hereafter "Henlius"). The deal grants Henlius exclusive development and commercialization rights to HCB101 across Greater China (including Mainland China, Hong Kong, and Macau), key Southeast Asian countries, as well as all countries in the Middle East and North Africa (MENA).

MUMBAI, Inde, 1er juillet 2025 /PRNewswire/ -- Piramal Pharma Solutions, une organisation de dveloppement et de fabrication sous contrat (CDMO) de premier plan mondial, qui fait partie de Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), a rcemment annonc un plan d'investissement de 90 millions de dollars pour agrandir deux de ses installations amricaines, qui sont essentielles son offre intgre. Cet investissement ambitieux souligne l'engagement de l'entreprise occuper une position de leader dans l'industrie grce une croissance et une innovation continues. Les deux sites concerns par l'extension sont:

OSLO, Norway, July 1, 2025 /PRNewswire/ -- Hemispherian AS, a pioneering biotech company developing next-generation therapeutics for aggressive cancers, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for GLIX1 for the treatment of malignant glioma, a category of devastating brain cancers that includes glioblastoma.

SHENZHEN, China, July 1, 2025 /PRNewswire/ --From June 11 to 13, the 2025WHX Miami Medical Expo (formerly known as FIME), the annual grand event of the medical industry in the Americas, was held at the Miami Beach Convention Center. As one of the largest and most influential professional exhibitions for medical devices and equipment in the Americas, WHX Miami attracted top companies from around the world, serving as a vital hub connecting the healthcare markets of North America, South America, and the Caribbean. Among the many exhibitors, Shenzhen Zuowei Technology Co., Ltd. from China stood out with its impressive presence. Its cutting-edge intelligent nursing robots and innovative solutions became a highlight of the expo, drawing significant attention from attendees and industry professionals alike.

GOTHENBURG, Sweden, July 1, 2025 /PRNewswire/ -- Vitrolife AB (publ) has today renewed and signed a loan agreement of EUR 300 million comprising of term loan and revolving credit facility. The term loan will be used to refinance existing debt and the revolving credit facility will be available for general corporate purposes.

SHANGHAI and SINGAPORE, July 1, 2025 /PRNewswire/ -- On June 30, WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, announced that the mechanical completion of its manufacturing site atTuas Biomedical Park in Singapore has been successfully achieved. This milestone signifies that this manufacturing site, spanning approximately 25,000 square meters, will now officially transition into the facility C&Q (Commissioning and Qualification) stage. The Singapore site is expected to commence operations by the end of 2025 and Good Manufacturing Practice (GMP) manufacturing in 2026. Upon that, the site will offer comprehensive production capabilities from the preclinical stage to commercialization.

LUND, Sweden, July 1, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the European Commission (EC) has granted Oczyesa, octreotide subcutaneous depot, marketing authorization* for the maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogs.1

LUND, Sweden, July 1, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the European Commission (EC) has granted Oczyesa, octreotide subcutaneous depot, marketing authorization* for the maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogs.1

Enhanced incentives, a renewed brand story, and stronger sales system are aimed at driving early success and sustainable growth for USANA Brand Partners

Wsparcie wsppracy Chiny-Europa w kierunku zielonej i niskoemisyjnej przyszoci.

Solutions focus on enhancing crop resilience, protecting yields, and addressing critical challenges in the global food system

VADUZ,Liechtenstein, July 1, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of treatment for acid reflux with its unique device RefluxStop, a treatment field with 1 billion sufferers, announces the publication of RefluxStop's extraordinary 5-year clinical data for food passageway-related outcomes in the prestigious journal, Surgical Endoscopy, an official journal of SAGES (American Gastrointestinal and Endoscopic Surgeons) and EAES (European Association For Endoscopic Surgery).

FLORENCE, Italy, July 1, 2025 /PRNewswire/ -- Surprises never end when it comes to the Fair Play Menarini International Award: Lus Figo, European football legend and true icon of sporting integrity, will be among the awardees of the 29th edition of the event, taking place on July 2nd and 3rd in Florence and Fiesole. With his charisma, and a career marked by international successes and unwavering respect for the rules, the Portuguese sports star fully embodies the founding values of the Award.

DENVER, July 1, 2025 /PRNewswire/ -- TRC Healthcare, the leading provider of evidence-based medication-related resources, announced last week the launch of an upgraded NatMed Pro, the largest unbiased natural medicines database available to healthcare, research, and industry professionals. Built on trusted independent evidence-free from commercial influence-NatMed Pro delivers objective insights clinicians and researchers can trust. The redesigned platform now offers faster performance, mobile access, and seamless data integration.

The German Design Council has once again honored outstanding innovations in Berlin. Among the award recipients: DERMALOG Identification Systems GmbH, recognized for its Self Registration Kiosk featuring the integrated all-in-one VF1 scanner - a solution setting new benchmarks for digital security and seamless enrollment processes.

Le Conseil allemand du design a une nouvelle fois rcompens des innovations exceptionnelles Berlin. Parmi les laurats : DERMALOG Identification Systems GmbH pour son kiosque d'enregistrement autonome, quip du scanner multifonction VF1 - une solution qui redfinit les standards de scurit numrique et de simplicit d'inscription.

El Consejo Alemn de Diseo volvi a premiar en Berln las innovaciones ms destacadas. Entre los galardonados se encuentra DERMALOG Identification Systems por su quiosco de registro autoservicio con el escner todo en uno VF1 integrado, una solucin que marca un nuevo referente en seguridad digital y procesos de registro cmodos.

BRUSSELS, June 30, 2025 /PRNewswire/ -- Obesity is fuelling a sharp rise in digestive diseases and cancers across Europe, particularly among people under 50, where stigma and low awareness delay early diagnosis. In response, United EuropeanGastroenterology (UEG) hosted Connecting the Dots: Obesity, Digestive Diseases and Cancers at the European Parliament on 5 June. The event brought together policymakers, clinicians, patient advocates, and public health leaders to push for urgent, coordinated action.

A new international study presented today at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) reveals that IVF cycles involving male partners over the age of 45 carry significantly increased miscarriage risks and lower live birth rates - even when young donor eggs are used.

BRUSELAS, 30 de junio de 2025 /PRNewswire/ --La obesidad est provocando un fuerte aumento de las enfermedades digestivas y los cnceres en toda Europa, sobre todo entre los menores de 50 aos, donde el estigma y el escaso conocimiento retrasan el diagnstico precoz. En respuesta a esta situacin, United European Gastroenterology (UEG) organiz el 5 de junio en el Parlamento Europeo el evento Connecting the Dots: Obesity, Digestive Diseases and Cancers. El acto reuni a responsables polticos, mdicos, defensores de los pacientes y lderes de la sanidad pblica para impulsar una accin urgente y coordinada.

41 Reunin Anual deESHRE: La edad paterna avanzada se relaciona con un mayor riesgo de aborto espontneo y menores tasas de nacidos vivos en ciclos de FIV con vulos de donante

BRUXELLES, 30 juin 2025 /PRNewswire/ -- L'obsit alimente une forte augmentation des maladies digestives et des cancers en Europe, en particulier chez les personnes de moins de 50 ans, o la stigmatisation et le manque de sensibilisation retardent le diagnostic prcoce. En rponse, United European Gastroenterology (UEG) a organis Connecting the Dots : Obesity, Digestive Diseases and Cancers au Parlement europen le 5 juin. L'vnement a rassembl des dcideurs politiques, des cliniciens, des dfenseurs des patients et des responsables de la sant publique afin d'encourager une action urgente et coordonne.